Clarentis Overview
Latest Deal Type
Series A
Clarentis General Information
Description
Manufacturer of non-toxic disinfectant and anti-microbial products created to generate high-quality, pure HOCl from to produce the biocidal disinfectant. The company's disinfectant and anti-microbial products kill common bacteria across a broad spectrum of applications and also eradicate antibiotic-resistant strains of the virulent pathogens found around the globe, enabling customers to reduce the number of chemicals that they use to purify.
Want to dig into this profile?
We’ll help you find what you need
Learn more
Clarentis Valuation & Funding
| Deal Type |
Date |
Amount |
Raised to Date |
Post-Val |
Status |
Stage |
| 1. Early Stage VC (Series A) |
01-Sep-2014 |
$10M |
0000 |
|
Completed |
Generating Revenue |
Clarentis Executive Team (2)
| Name |
Title |
Board Seat |
Contact Info |
| Duke Kalken |
Chief Executive Officer |
|
|
1 Former Executive